Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Restaurant Industry News McDonald’s E. coli outbreak expands, sickens over 75 across multiple states A growing E. coli outbreak linked to McDonald’s Quarter Pounder hamburgers has alarmed health officials and consumers alike,… byPallavi MadhirajuOctober 26, 2024